Search - tctmd.com

Displaying 281 - 300 of 353

Sort: Relevancy | Date

News Conference News AHA 2015

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

Yael L. Maxwell

November 09, 2015

News Daily News

Door Closing on Low-fat Diets for Long-term Weight Management

Todd Neale

November 01, 2015

News Conference News TCT 2015

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Nicole Lou

October 13, 2015

News Industry News

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

September 18, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Industry News

LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker

August 31, 2015

News Daily News

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Caitlin E. Cox

August 24, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

August 11, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Industry News

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

July 06, 2015

News Daily News

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

Todd Neale

June 29, 2015

News Industry News

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

June 16, 2015

News Industry News

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

June 05, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Daily News

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

L.A. McKeown

May 04, 2015

News Daily News

Silent A-fib After Acute MI Portends Poor Outcome

Yael L. Maxwell

May 01, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

Advertisement

Leadless Transcatheter Pacing Looks Good in the Short-term, But Long-term Questions Remain

Door Closing on Low-fat Diets for Long-term Weight Management

TOTAL: Manual Thrombectomy Does Not Benefit STEMI Patients at 1 Year

Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

LEADLESS II Trial Results Published in The New England Journal of Medicine Confirm the Positive Benefits of the Nanostim Leadless Pacemaker

CAD Location May Influence Need for Prolonged DAPT Post-PCI

Novel Antisense Inhibitor Cuts High Triglyceride Levels

CHOICE at 1 Year: Sapien, CoreValve Yield Similar Clinical Outcomes

DES, BMS Both Suitable for Treating Patients With SVG Lesions

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Hansen Medical® Announces Successful Enrollment of Initial Cohort in Artisan® U.S. Clinical Trial

FDA Approval of Cangrelor Expands Antiplatelet Options for PCI

GORE® EXCLUDER® Conformable AAA Endoprosthesis Receives Approval for Clinical Study in the US and Japan

Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

Real-World Studies Highlight GI Bleeding Concerns With Newer Anticoagulants

Silent A-fib After Acute MI Portends Poor Outcome

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content